On the 3rd, the US FDA announced the approval of the listing of the CD38 antibody Sarclisa (isatuximab-irfc) developed by Sanofi (Sanofi) for use in combination with pomalidomide and dexamethasone to
Read More >>
On the 3rd, the US FDA announced the approval of the listing of the CD38 antibody Sarclisa (isatuximab-irfc) developed by Sanofi (Sanofi) for use in combination with pomalidomide and dexamethasone to
With the continuous improvement of the medical security level of more than 1.3 billion people, my country's biomedical industry has huge market space. Compared with advanced countries in the world
The newly revised "Regulations for the Supervision and Administration of Medical Devices" (hereinafter referred to as the "Regulations") have been implemented since June 1, 2014. I
Editor's note: Recently, the National Health Commission responded to Recommendation No. 6238 of the First Session of the 13th National People's Congress. The reply stated that the National Hea
